Röntgentekno Oy, also known as Imaqen Ltd., is a leading Finnish healthcare technology company at the forefront of smart healthcare. They specialize in developing innovative solutions for early cancer detection, offering non-invasive patient examinations suitable for a wide range of healthcare facilities. Their groundbreaking pre-screening solution utilizes a patented method that has been proven effective.

Composed of experienced diagnostic imaging and clinical research professionals, their team has a proven track record in successful product development and global sales and marketing. Imaqen Ltd. They have received funding from the European Union's Horizon 2020 program, which is dedicated to research and innovation.

In addition to their cancer detection solution, they also provide a comprehensive range of products and services for medical device manufacturers and healthcare providers. These include quality assurance tools, educational courses for diagnostic imaging, and services to enhance the performance of healthcare practices. Visit their website to learn more about their offerings and join their journey to revolutionize healthcare